Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SUTRO BIOPHARMA, INC.

(STRO)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 30-09-2022
5.550 USD   +2.21%
23/08Sutro Biopharma, Inc. : Truist Securities herhaalt koopadvies voor het aandeel
MM
09/08Sutro Biopharma, Inc. : Berenberg Bank herhaalt koopadvies
MM
08/08Sutro Biopharma, Inc. Rapporteert Winstresultaten voor het Tweede Kwartaal en de Zes Maanden Geëindigd op 30 Juni, 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Communiqués de presse de la société SUTRO BIOPHARMA, INC.
01/09Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference
AQ
19/08Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/08Sutro Biopharma : Reports Second Quarter 2022 Financial Results, Business Highlights and A..
PU
08/08SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
08/08Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and ..
AQ
03/08Sutro Biopharma to Present at the 2022 Wedbush PacGrow Healthcare Conference
AQ
27/07Sutro Biopharma Achieves 'First in Human' Milestone in Cytokine Derivatives Collaborati..
AQ
26/07Sutro Biopharma, Inc. : Other Events (form 8-K)
AQ
26/07Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives..
AQ
12/07Sutro Biopharma Announces Virtual De : Next-Gen Innovations in ADCs
AQ
28/06Sutro Biopharma, Inc. : Entry into a Material Definitive Agreement, Other Events, Financia..
AQ
28/06Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Nove..
AQ
24/06Sutro Biopharma : 22nd Annual Federation of Clinical Immunology Societies (FOCIS) Meeting ..
PU
16/06Sutro Biopharma : JMP Securities Life Sciences Conference – Presentation
PU
16/06Sutro Biopharma, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/06Sutro Biopharma, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/06Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
04/06Sutro Biopharma : 2022 ASCO Annual Meeting – Abstract
PU
03/06Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
02/06Sutro Biopharma : Bill Newell, CEO Interviewed by Dr. Michelle McMurry-Heath on I Am Bio P..
PU
02/06Sutro Biopharma : Participated in a Clinical Trial, “Egg-Derived Anti-SARS-CoV-2 Imm..
PU
02/06Sutro Biopharma to Participate in Upcoming Investor Conferences
AQ
09/05SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
09/05Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and ..
AQ
02/05Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
29/04Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
20/04Sutro Biopharma, Inc. : Entry into a Material Definitive Agreement (form 8-K)
AQ
11/04Sutro Biopharma : Kristin Bedard, Ph.D., VP of Discovery interviewed by Gail Dutton, BioSp..
PU
08/04Sutro Biopharma : American Association for Cancer Research (AACR) Annual Meeting 2022 &nda..
PU
05/04Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference
PR
30/03Sutro Biopharma : 12th Annual World ADC London 2022 – Presentations
PU
30/03Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugat..
PR
03/03Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
PR
01/03Sutro Biopharma : Reports Full Year 2021 Financial Results, Business Highlights, and Antic..
PU
28/02SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
28/02Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anti..
PR
11/01Sutro Biopharma : 63rd American Society of Hematology (ASH) Annual Meeting and Exposition ..
PU
10/01Sutro Biopharma : 40th Annual J.P. Morgan Heathcare Conference – Presentation
PU
10/01Sutro Biopharma, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
06/01Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
PR
05/01Sutro Biopharma : Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 St..
PU
05/01Sutro Biopharma : 2022 KOL Discussion of STRO-002 Phase 1 Interim Dose Expansion Data &nda..
PU
05/01Sutro Biopharma, Inc. : Regulation FD Disclosure, Other Events, Financial Statements and E..
AQ
05/01Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 S..
PR
2021Sutro Biopharma, Inc. : Entry into a Material Definitive Agreement (form 8-K)
AQ
2021Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion D..
PR
2021Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for..
PR
2021Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present..
AQ
2021Sutro Biopharma : 4th Annual Evercore ISI HeathCONx Conference – Presentation
PU
2021Sutro Biopharma : Piper Sandler 33rd Annual Healthcare Conference – Presentation
PU
2021Sutro Biopharma to Participate in Two Upcoming Investor Conferences
PR
2021Sutro Biopharma : Jefferies London Healthcare Conference – Presentation
PU
2021Sutro Biopharma, Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors
PR
2021Sutro Biopharma : Stifel 2021 Virtual Healthcare Conference – Presentation
PU
2021Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and ..
AQ
2021Credit Suisse 30th Annual Healthcare Conference – Presentation
PU
2021Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and ..
PU
2021Sutro Biopharma, Inc. : Results of Operations and Financial Condition, Regulation FD Discl..
AQ
2021SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
2021Sutro Biopharma to Participate in Three Upcoming Investor Conferences
PR
2021Sutro Biopharma : Extern, Protein Expression and Bioconjugation
PU
2021Sutro Biopharma : Material Definitive Agreement - Form 8-K
PU
2021Sutro Biopharma, Inc. : Entry into a Material Definitive Agreement (form 8-K)
AQ
2021Sutro Biopharma : and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Gre..
PR
2021Sutro Biopharma, Inc. : Other Events (form 8-K)
AQ
2021Sutro Biopharma : Announces Extension of Cytokine Derivative Research Program Under Collab..
PR
2021Sutro Biopharma : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
2021Sutro Biopharma : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
2021Sutro Biopharma : Announces Expansion of Leadership Team
PR
2021Sutro Biopharma : Senior Scientist, Analytical & Formulation Development
PU
2021Sutro Biopharma : 2021 Wells Fargo Virtual Healthcare Conference – Presentation
PU
2021Sutro Biopharma : to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
PR
2021Sutro Biopharma : Announces STRO-002 FDA Fast Track Designation for Patients with Advanced..
PR
2021Sutro Biopharma : 12th Annual Wedbush PacGrow Healthcare Virtual Conference 2021 – P..
PU
1  2  3  4Volgende
Volgende evenement op SUTRO BIOPHARMA, INC.